Careers
Celea Therapeutics
celeatx.comindustry
Biopharma · Biotechnology · Clinical Trials · Health Care · Medical · Pharmaceutical · Therapeutics
Stage
Private Equity
founded in
2025
Socials
About
Celea Therapeutics develops drug therapies for serious respiratory and fibrotic lung diseases. The company focuses on Idiopathic Pulmonary Fibrosis (IPF) and is advancing Deupirfenidone (LYT-100), an oral investigational therapy. Deupirfenidone is being studied as a potential new standard of care for IPF, with completed Phase 2b data and a pivotal Phase 3 trial planned. Celea also runs an open-label extension study to assess long-term outcomes and collaborates with clinicians and patient groups on IPF patient experience research. Celea is a wholly-owned subsidiary of PureTech Health plc.
Open jobs at Celea Therapeutics
On-site & Remote
Job function
Seniority
Salary